ESTRO GUIDE 2017

PREREQUISITES Before commencing this course participants should have basic experience with patients experiencing adverse events of radio(chemo)therapy.

ROADMAP

TEACHINGMETHODS • >15 hours of lectures • >2 hours of case discussions • 1 hour of general discussion.

MULTIMODAL CANCER TREATMENT

RADIATION ONCOLOGIST, RADIATION THERAPIST

FACULTY COURSE DIRECTOR Wolfgang Dörr, Radiation Biologist, Medical University of Vienna, Vienna (AT) COURSE CO-DIRECTOR Hans Langendijk, Radiation Oncologist, University Medical Centre Groningen, Groningen (NL) TEACHERS • Nicolaus Andratschke, Radiation Oncologist, University Hospital Rostock, Rostock (DE) • Jervoise Andreyev, Gastroenterologist, The Royal Marsden Hospital, London (UK) • Karin Dieckmann, Radiation Oncologist, University Hospital Vienna, Vienna (AT) • Sjoukje Oosting, Medical Oncologist, University Medical Center Groningen, Groningen (NL) • John Ramage, Lead clinician, Kings Health Partners Neuroendocrine Centre, Kings College London; Professor of Healthcare Research University of Winchester, Winchester (UK)

METHODS OF ASSESSMENT • MCQ • Evaluation form • Clinical case discussions.

KEYWORDS Cancer survivorship, morbidity, quality-of-life.

FURTHER READING Please consult the ESTRO website page of this course for further information.

ACCREDITATION Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EAC- CME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.

Hans Langendijk

Wolfgang Dörr

ESTRO SCHOOL

49